Compound Summary: glibenclamide

species organ dose type of experiment single/repeat period signature pathway
Rat Liver 100mg in_vivo Single 3h link link
Rat Liver 100mg in_vivo Single 6h link link
Rat Liver 100mg in_vivo Single 9h link link
Rat Liver 100mg in_vivo Single 24h link link
Rat Liver 300mg in_vivo Single 3h link link
Rat Liver 300mg in_vivo Single 6h link link
Rat Liver 300mg in_vivo Single 9h link link
Rat Liver 300mg in_vivo Single 24h link link
Rat Liver 1000mg in_vivo Single 3h link link
Rat Liver 1000mg in_vivo Single 6h link link
Rat Liver 1000mg in_vivo Single 9h link link
Rat Liver 1000mg in_vivo Single 24h link link
Rat Liver 100mg in_vivo Repeat 4d link link
Rat Liver 100mg in_vivo Repeat 8d link link
Rat Liver 100mg in_vivo Repeat 15d link link
Rat Liver 100mg in_vivo Repeat 29d link link
Rat Liver 300mg in_vivo Repeat 4d link link
Rat Liver 300mg in_vivo Repeat 8d link link
Rat Liver 300mg in_vivo Repeat 15d link link
Rat Liver 300mg in_vivo Repeat 29d link link
Rat Liver 1000mg in_vivo Repeat 4d link link
Rat Liver 1000mg in_vivo Repeat 8d link link
Rat Liver 1000mg in_vivo Repeat 15d link link
Rat Liver 1000mg in_vivo Repeat 29d link link
Rat Liver 2.4microM in_vitro 2h link link
Rat Liver 2.4microM in_vitro 8h link link
Rat Liver 2.4microM in_vitro 24h link link
Rat Liver 12microM in_vitro 2h link link
Rat Liver 12microM in_vitro 8h link link
Rat Liver 12microM in_vitro 24h link link
Rat Liver 60microM in_vitro 2h link link
Rat Liver 60microM in_vitro 8h link link
Rat Liver 60microM in_vitro 24h link link
Human Liver 0.8microM in_vitro 2h link link
Human Liver 0.8microM in_vitro 8h link link
Human Liver 0.8microM in_vitro 24h link link
Human Liver 4microM in_vitro 2h link link
Human Liver 4microM in_vitro 8h link link
Human Liver 4microM in_vitro 24h link link
Human Liver 20microM in_vitro 2h link link
Human Liver 20microM in_vitro 8h link link
Human Liver 20microM in_vitro 24h link link